4L5-23412-68740
3 vaccinations
1 coded response
30 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 902 / CA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-28
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-13
- 2021-12-31
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID infection this weekMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-10-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-01 | Successful 2022-04-05 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 6 months, dose 3
Symptoms: COVID infection this week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release